Jungbluth G L, Cooper D L, Doyle G D, Chudzik G M, Jusko W J
Antimicrob Agents Chemother. 1986 Dec;30(6):896-900. doi: 10.1128/AAC.30.6.896.
The disposition of coadministered ticarcillin (3 g/1.73 m2) and clavulanic acid (100 mg/1.73 m2) was examined after a 30-min infusion in 24 noninfected subjects with various degrees of renal function. Noncompartmental pharmacokinetic parameters for the individual compounds were determined from plasma concentrations and urinary excretion rates. All clearances (total, renal, and nonrenal) and urinary recoveries of unchanged drug were found to be linearly related to creatinine clearance (CLCR). The steady-state volume of distribution (9.9 and 12.9 liters for ticarcillin and clavulanic acid) approximated the extracellular fluid space and was not related to CLCR. The half-lives increased with reduced renal function and ranged from 56 to 392 min for ticarcillin and 26 to 266 min for clavulanic acid. The clearances of both drugs decreased proportionately with reduction in renal function, facilitating dosing adjustments based on CLCR. Calculations of expected steady-state maximum and minimum concentrations in plasma using constant doses and an extended dosing interval related to CLCR further rationalized use of the 30:1 drug combination ratio for all patients.
在24名不同程度肾功能的未感染受试者中,静脉输注30分钟后,研究了联合使用替卡西林(3 g/1.73 m²)和克拉维酸(100 mg/1.73 m²)的处置情况。根据血浆浓度和尿排泄率确定了各化合物的非房室药代动力学参数。发现所有清除率(总清除率、肾清除率和非肾清除率)和原形药物的尿回收率均与肌酐清除率(CLCR)呈线性相关。稳态分布容积(替卡西林和克拉维酸分别为9.9和12.9升)接近细胞外液空间,且与CLCR无关。半衰期随肾功能降低而延长,替卡西林的半衰期为56至392分钟,克拉维酸的半衰期为26至266分钟。两种药物的清除率均随肾功能降低而按比例下降,这有助于根据CLCR调整给药剂量。使用固定剂量和与CLCR相关的延长给药间隔计算血浆中预期的稳态最大和最小浓度,进一步合理确定了所有患者30:1药物组合比例的使用。